Abstract
摘要
相似文献
1
The prostate question, unanswered still.前列腺问题，依旧悬而未决。
Lancet. 1997 Feb 15;349(9050):443.
2
Screening for prostate cancer.
Lancet. 1997 Apr 12;349(9058):1098. doi: 10.1016/S0140-6736(97)26015-0.
3
Screening for prostate cancer.
Lancet. 1997 Apr 12;349(9058):1098-9. doi: 10.1016/S0140-6736(05)62316-1.
4
Storm over screening for prostate specific antigen. Right to choose is important.前列腺特异性抗原筛查引发的风波。选择权很重要。
BMJ. 2002 Jun 8;324(7350):1392.
5
Screening for prostate cancer. The case against.
Ann R Coll Surg Engl. 2005 Mar;87(2):90-1; discussion 88.
6
Screening for prostate cancer: the case for.前列腺癌筛查：支持的理由
Ann R Coll Surg Engl. 2005 Mar;87(2):88-9; discussion 88.
7
Screening for prostate cancer.
Br J Hosp Med. 1997;58(10):484, 486.
8
Screening for prostate cancer. Consider the harms.前列腺癌筛查。考虑其危害。
BMJ. 2010 Oct 26;341:c5811. doi: 10.1136/bmj.c5811.
9
The jury is still out with regard to screening for the prostate cancer with prostate-specific antigen.关于用前列腺特异性抗原筛查前列腺癌，尚无定论。
Eur J Cancer Care (Engl). 2002 Jun;11(2):78.
10
Prostate-specific antigen testing in healthy men: a U.K. perspective.健康男性的前列腺特异性抗原检测：英国视角
Clin Oncol (R Coll Radiol). 2005 Jun;17(4):228-30. doi: 10.1016/j.clon.2005.03.003.
引用本文的文献
1
Health technology assessment--the role of the pharmaceutical panel.卫生技术评估——药物评估小组的作用
Br J Clin Pharmacol. 1998 Mar;45(3):217-20. doi: 10.1046/j.1365-2125.1998.00678.x.
Zotero 插件